Steroid prophylaxis after radioiodine treatment for graves' hyperthyroidism: Selective or universal?

Thyroid

Volumn 24, Issue 10, 2014, Pages 1441-1442

  Bartalena, Luigi ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; GLUCOCORTICOID; LIOTRIX; PREDNISONE; RADIOACTIVE IODINE; STEROID; RADIOPHARMACEUTICAL AGENT;

CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; META ANALYSIS (TOPIC); PROPHYLAXIS; STEROID THERAPY; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC THERAPY; GRAVES OPHTHALMOPATHY;

GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; IODINE RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 84911943289     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0349     Document Type: Editorial

References (9)

1. Bartalena L, Fatourechi V 2014 Extrathyroidal manifestations of Graves' disease: a 2014 update. J Endocrinol Invest 37:691-700.
2. Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L 2013 Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98:1443-1449.
3. Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L 2013 Prevalence and natural history of Graves' orbitopathy in the XXI century. J Endocrinol Invest 36:444-449.
4. Traisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorf J, Hallengren B, Hedner P, lantz M, Nystrom E, Pnjavic V, Taube A, Torring O, Wallin G, Asman P, Lundell G 2009 Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab 94:3700-3707.
5. Tallstedt L, Lundell G, Blomgren H, Bring J 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130:494-497.
6. Bartalena L 2011 The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. J Clin Endocrinol Metab 96:592-599.
7. Shiber S, Stiebel-Kalish H, Shimon I, Grossman A, Robensthok E 2014 Glucocorticoids regimens for prevention of Graves' ophthalmopathy progression following radioiodine treatment - Systematic review and meta-analysis. Thyroid 24:1515-1523.
8. Bartalena L, Krassas GE, Wiersinga W, Marcocci C, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Veronesi C, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Currò N, Boschi A, Bernard M, von Arx G, European Group on Graves' Orbitopathy 2012 Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. J Clin Endocrinol Metab 97:4454-4463.
9. Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J 2005 A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 90:5321-5323.